The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 02, 2024
Filed:
Sep. 04, 2020
Applicant:
Gw Pharma Limited, Salisbury, GB;
Inventors:
Ben Whalley, Reading, GB;
Claire Williams, Reading, GB;
Gary Stephens, Reading, GB;
Takashi Futamura, Osaka, JP;
Assignee:
GW Pharma Limited, Cambridge, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/05 (2006.01); A61K 31/19 (2006.01); A61K 31/352 (2006.01); A61K 31/40 (2006.01); A61K 31/515 (2006.01); A61K 36/185 (2006.01); A61K 45/06 (2006.01); A61P 25/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/19 (2013.01); A61K 31/352 (2013.01); A61K 31/40 (2013.01); A61K 31/515 (2013.01); A61K 36/185 (2013.01); A61K 45/06 (2013.01); A61P 25/08 (2018.01);
Abstract
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.